Miles Darrin 4
4 · AGIOS PHARMACEUTICALS, INC. · Filed Feb 24, 2021
Insider Transaction Report
Form 4
Miles Darrin
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common stock
2021-02-22+725→ 13,272 total - Tax Payment
Common stock
2021-02-22−215→ 13,057 total - Exercise/Conversion
Restricted stock units
2021-02-22−725→ 724 total→ Common stock (725 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F2]The restricted stock units were granted on February 22, 2019. Beginning on February 22, 2020, the shares underlying the restricted stock units will vest in three equal annual installments.